Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Estimating the potential public health value of BCG revaccinationFriday, August 9, 2024Availability, Epidemiological impactRead More
Acceptability and effect on public and cost-effectiveness impactFriday, August 9, 2024Acceptability and demand, Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South AfricaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesFriday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
